Lyka Labs · NSE: LYKALABS · BSE: 500259
Q4 FY23 results · Jan–Mar 2023
Lyka Labs reported revenue from operations of ₹22.24 crore (down 36.8% from Q4 FY22) and net loss of ₹3.00 crore for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 22.24 | 35.19 | −36.8% | 17.82 | +24.8% |
| Other income | 0.43 | 0.53 | −19.6% | 1.06 | −59.7% |
| Total income | 22.67 | 35.72 | −36.5% | 18.88 | +20.1% |
| Profit before tax | (3.00) | (2.12) | Loss widened | (10.29) | Loss narrowed |
| Net profit for the period | (3.00) | (15.07) | Loss narrowed | (10.52) | Loss narrowed |
| EPS, basic (₹) | (1.05) | (5.26) | Loss narrowed | (3.64) | Loss narrowed |
| Net margin (%) | -13.5 | -42.8 | -59.1 |
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 19.46 | 27.68 | −29.7% | 17.13 | +13.6% |
| Other income | 0.61 | 0.66 | −6.8% | 1.11 | −44.8% |
| Total income | 20.07 | 28.34 | −29.2% | 18.25 | +10.0% |
| Profit before tax | (2.93) | (2.62) | Loss widened | (9.93) | Loss narrowed |
| Net profit for the period | (3.01) | (15.24) | Loss narrowed | (10.21) | Loss narrowed |
| EPS, basic (₹) | (1.05) | (5.32) | Loss narrowed | (3.57) | Loss narrowed |
| Net margin (%) | -15.4 | -55.0 | -59.6 |
Consolidated
- Filed with BSE
- 24 May 2023, 09:43 IST
- Board meeting
- 23 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 24 May 2023, 09:43 IST
- Board meeting
- 23 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE